<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39223749</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2982</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Neurogastroenterology and motility</Title><ISOAbbreviation>Neurogastroenterol Motil</ISOAbbreviation></Journal><ArticleTitle>Somatic, emotional, and gastrointestinal symptom severity are increased among children and adolescents with COVID-19.</ArticleTitle><Pagination><StartPage>e14909</StartPage><MedlinePgn>e14909</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/nmo.14909</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Post-infectious disorders of gut-brain interaction (PI-DGBI) have significant impact on children and adolescents. The effect of COVID-19 on PI-DGBI-associated symptoms in this population, however, is unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed electronic medical record searches to identify patients 8-17&#x2009;years old with a SARS-CoV2 PCR test at Lurie Children's Hospital between November 2020 and March 2021 (cohort 1) and April-October 2021 (cohort 2). Questionnaires were administered to assess symptoms prior to and 3&#x2009;months following the test. This included the Pediatric Eosinophilic Esophagitis Symptom Score (PEESS), questionnaire of pediatric gastrointestinal symptoms-Rome IV, Nausea Profile (NP), dyspepsia symptom survey (DSS), nausea severity profile (NSP), and Pediatric Quality of Life Inventory (PedsQL). We grouped patients based on the presence of symptoms prior to COVID-19 test or the test result.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred and ninety-six parent(s) or guardian(s) in cohort 1 and 274 in cohort 2 completed surveys and self-reported their child's COVID-19 result. Cohort 1 had increased PEESS and DSS scores, lower PedsQL scores, and increased frequency of abdominal pain disorders among patients with symptoms prior to COVID-19 testing. Both cohorts had increased NP and NSP scores among patients with symptoms prior to COVID-19 testing that was highest among patients with a positive COVID-19 test. Abdominal pain and diarrhea prior to COVID-19 testing predicted higher NP scores.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among symptomatic COVID-19 tested children, we found increased severity of nausea-associated somatic, emotional, and gastrointestinal symptoms in the 3&#x2009;months following the test that was most increased among patients with a positive COVID-19 test.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Neurogastroenterology &amp; Motility published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wechsler</LastName><ForeName>Joshua B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0002-1275-3275</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology and Nutrition, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berken</LastName><ForeName>Jonathan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology and Nutrition, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keeley</LastName><ForeName>Kaitlyn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology and Nutrition, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jhaveri</LastName><ForeName>Ravi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Ben Z</ForeName><Initials>BZ</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortunato</LastName><ForeName>John E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology and Nutrition, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saps</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4507-8720</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Miami Children's Hospital, University of Miami Health System, Miami, Florida, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Campaign Urging Research for Eosinophilic Disease</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Neurogastroenterol Motil</MedlineTA><NlmUniqueID>9432572</NlmUniqueID><ISSNLinking>1350-1925</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009325" MajorTopicYN="N">Nausea</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087502" MajorTopicYN="N">Brain-Gut Axis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">PI&#x2010;IBS</Keyword><Keyword MajorTopicYN="N">functional gastrointestinal</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pediatric</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>3</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39223749</ArticleId><ArticleId IdType="doi">10.1111/nmo.14909</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Pensabene L, Talarico V, Concolino D, et&#xa0;al. Postinfectious functional gastrointestinal disorders in children: a multicenter prospective study. J Pediatr. 2015;166(903&#x2013;7):e1.</Citation></Reference><Reference><Citation>Saps M, Pensabene L, Di Martino L, et&#xa0;al. Post&#x2010;infectious functional gastrointestinal disorders in children. J Pediatr. 2008;152:812&#x2010;816 e1.</Citation></Reference><Reference><Citation>Shafiei Z, Esfandiari F, Sarkari B, et&#xa0;al. Parasitic infections in irritable bowel syndrome patients: evidence to propose a possible link, based on a case&#x2010;control study in the South of Iran. BMC Res Notes. 2020;13:264.</Citation></Reference><Reference><Citation>Velasco&#x2010;Benitez CA, Ortiz&#x2010;Rivera CJ. Post&#x2010;infectious functional gastrointestinal disorders in children after a non&#x2010;severe dengue episode without warning signs. Biomedica. 2019;39:93&#x2010;100.</Citation></Reference><Reference><Citation>Berumen A, Edwinson AL, Grover M. Post&#x2010;infection irritable bowel syndrome. Gastroenterol Clin N Am. 2021;50:445&#x2010;461.</Citation></Reference><Reference><Citation>Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ. Functional dyspepsia. Lancet. 2020;396:1689&#x2010;1702.</Citation></Reference><Reference><Citation>Koppen IJ, Nurko S, Saps M, di Lorenzo C, Benninga MA. The pediatric Rome IV criteria: what's new? Expert Rev Gastroenterol Hepatol. 2017;11:193&#x2010;201.</Citation></Reference><Reference><Citation>Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. 2017;23:151&#x2010;163.</Citation></Reference><Reference><Citation>Manabe N, Tanaka T, Hata J, Kusunoki H, Haruma K. Pathophysiology underlying irritable bowel syndrome&#x2013;from the viewpoint of dysfunction of autonomic nervous system activity. J Smooth Muscle Res. 2009;45:15&#x2010;23.</Citation></Reference><Reference><Citation>Borgaonkar MR, Ford DC, Marshall JK, Churchill E, Collins SM. The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci. 2006;51:1026&#x2010;1032.</Citation></Reference><Reference><Citation>Boronat AC, Ferreira&#x2010;Maia AP, Matijasevich A, Wang YP. Epidemiology of functional gastrointestinal disorders in children and adolescents: a systematic review. World J Gastroenterol. 2017;23:3915&#x2010;3927.</Citation></Reference><Reference><Citation>Klem F, Wadhwa A, Prokop LJ, et&#xa0;al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta&#x2010;analysis. Gastroenterology. 2017;152:1042&#x2010;1054.</Citation></Reference><Reference><Citation>Marshall JK, Thabane M, Borgaonkar MR, James C. Postinfectious irritable bowel syndrome after a food&#x2010;borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol. 2007;5:457.</Citation></Reference><Reference><Citation>Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ. 1999;318:565&#x2010;566.</Citation></Reference><Reference><Citation>Saps M, Pensabene L, Turco R, Staiano A, Cupuro D, di Lorenzo C. Rotavirus gastroenteritis: precursor of functional gastrointestinal disorders? J Pediatr Gastroenterol Nutr. 2009;49:580&#x2010;583.</Citation></Reference><Reference><Citation>Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology. 2011;140:761&#x2010;765.</Citation></Reference><Reference><Citation>Sayed IA, Bhalala U, Strom L, et&#xa0;al. Gastrointestinal manifestations in hospitalized children with acute SARS&#x2010;CoV&#x2010;2 infection and multisystem inflammatory condition: an analysis of the Virus COVID&#x2010;19 registry. Pediatr Infect Dis J. 2022;41(9):751.</Citation></Reference><Reference><Citation>Pan L, Mu M, Yang P, et&#xa0;al. Clinical characteristics of COVID&#x2010;19 patients with digestive symptoms in Hubei, China: a descriptive, cross&#x2010;sectional, multicenter study. Am J Gastroenterol. 2020;115:766&#x2010;773.</Citation></Reference><Reference><Citation>Schmulson M, Davalos MF, Berumen J. Beware: gastrointestinal symptoms can be a manifestation of COVID&#x2010;19. Rev Gastroenterol Mex (Engl Ed). 2020;85:282&#x2010;287.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et&#xa0;al. Global prevalence of post COVID&#x2010;19 condition or long COVID: a meta&#x2010;analysis and systematic review. J Infect Dis. 2022;226(9):1593.</Citation></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, et&#xa0;al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med (Lond). 2021;21:e63&#x2010;e67.</Citation></Reference><Reference><Citation>Choudhury A, Tariq R, Jena A, et&#xa0;al. Gastrointestinal manifestations of long COVID: a systematic review and meta&#x2010;analysis. Ther Adv Gastroenterol. 2022;15:17562848221118403.</Citation></Reference><Reference><Citation>Sandler CX, Wyller VBB, Moss&#x2010;Morris R, et&#xa0;al. Long COVID and post&#x2010;infective fatigue syndrome: a review. Open forum. Infect Dis. 2021;8:ofab440.</Citation></Reference><Reference><Citation>Pellegrino R, Chiappini E, Licari A, et&#xa0;al. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181(12):3995.</Citation></Reference><Reference><Citation>Martin LJ, Franciosi JP, Collins MH, et&#xa0;al. Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. J Allergy Clin Immunol. 2015;135:1519.</Citation></Reference><Reference><Citation>Bose P, Albright E, Idrees MT, et&#xa0;al. Eosinophilic esophagitis symptom scores are high in children without eosinophilic disease. J Pediatr Gastroenterol Nutr. 2022;74:396&#x2010;401.</Citation></Reference><Reference><Citation>Wagoner AL, Tarbell SE, Shaltout HA, et&#xa0;al. Chronic nausea and orthostatic intolerance: diagnostic utility of orthostatic challenge duration, Nausea Profile questionnaire, and neurohumoral measures. Neurogastroenterol Motil. 2018;30:e13433.</Citation></Reference><Reference><Citation>Russell AC, Stone AL, Wang A, et&#xa0;al. Development and validation of a nausea severity scale for assessment of nausea in children with abdominal pain&#x2010;related functional gastrointestinal disorders. Children (Basel). 2018;5:68.</Citation></Reference><Reference><Citation>Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. 2012;87:1196&#x2010;1201.</Citation></Reference><Reference><Citation>Velasco&#x2010;Benitez CA, Gomez&#x2010;Oliveros LF, Rubio&#x2010;Molina LM, et&#xa0;al. Diagnostic accuracy of the Rome IV criteria for the diagnosis of functional gastrointestinal disorders in children. J Pediatr Gastroenterol Nutr. 2021;72:538&#x2010;541.</Citation></Reference><Reference><Citation>Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800&#x2010;812.</Citation></Reference><Reference><Citation>Children and COVID&#x2010;19: State&#x2010;Level Data Report. American Academy of Pediatrics; 2022. https://www.aap.org/en/pages/2019&#x2010;novel&#x2010;coronavirus&#x2010;covid&#x2010;19&#x2010;infections/children&#x2010;and&#x2010;covid&#x2010;19&#x2010;state&#x2010;level&#x2010;data&#x2010;report/</Citation></Reference><Reference><Citation>Clarke KEN, Jones JM, Deng Y, et&#xa0;al. Seroprevalence of infection&#x2010;induced SARS&#x2010;CoV&#x2010;2 antibodies&#x2013;United States, September 2021&#x2010;February 2022. MMWR Morb Mortal Wkly Rep. 2022;71:606&#x2010;608.</Citation></Reference><Reference><Citation>Kalyanaraman M, Anderson MR. COVID&#x2010;19 in children. Pediatr Clin N Am. 2022;69:547&#x2010;571.</Citation></Reference><Reference><Citation>Guido CA, Lucidi F, Midulla F, et&#xa0;al. Neurological and psychological effects of long COVID in a young population: a cross&#x2010;sectional study. Front Neurol. 2022;13:925144.</Citation></Reference><Reference><Citation>Trott M, Driscoll R, Pardhan S. The prevalence of sensory changes in post&#x2010;COVID syndrome: a systematic review and meta&#x2010;analysis. Front Med (Lausanne). 2022;9:980253.</Citation></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Ayuzo Del Valle NC, et&#xa0;al. Long&#x2010;COVID in children and adolescents: a systematic review and meta&#x2010;analyses. Sci Rep. 2022;12:9950.</Citation></Reference><Reference><Citation>Stephenson T, Allin B, Nugawela MD, et&#xa0;al. Long COVID (post&#x2010;COVID&#x2010;19 condition) in children: a modified Delphi process. Arch Dis Child. 2022;107:674&#x2010;680.</Citation></Reference><Reference><Citation>Kikkenborg Berg S, Palm P, Nygaard U, et&#xa0;al. Long COVID symptoms in SARS&#x2010;CoV&#x2010;2&#x2010;positive children aged 0&#x2013;14&#x2009;years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross&#x2010;sectional study. Lancet Child Adolesc Health. 2022;6:614&#x2010;623.</Citation></Reference><Reference><Citation>Shah MM, Winn A, Dahl RM, Kniss KL, Silk BJ, Killerby ME. Seasonality of common human coronaviruses, United States, 2014&#x2013;2021(1). Emerg Infect Dis. 2022;28:1970&#x2010;1976.</Citation></Reference><Reference><Citation>Hamid S, Winn A, Parikh R, et&#xa0;al. Seasonality of respiratory syncytial virus&#x2013;United States, 2017&#x2013;2023. MMWR Morb Mortal Wkly Rep. 2023;72:355&#x2010;361.</Citation></Reference><Reference><Citation>Saps M, Blank C, Khan S, et&#xa0;al. Seasonal variation in the presentation of abdominal pain. J Pediatr Gastroenterol Nutr. 2008;46:279&#x2010;284.</Citation></Reference><Reference><Citation>Jason LA, Cotler J, Islam MF, Furst J, Katz BZ. Predictors for developing severe myalgic encephalomyelitis/chronic fatigue syndrome following infectious mononucleosis. J Rehabil Ther. 2022;4:1&#x2010;5.</Citation></Reference><Reference><Citation>Noviello D, Costantino A, Muscatello A, et&#xa0;al. Functional gastrointestinal and somatoform symptoms five months after SARS&#x2010;CoV&#x2010;2 infection: a controlled cohort study. Neurogastroenterol Motil. 2022;34:e14187.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et&#xa0;al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2010;232.</Citation></Reference><Reference><Citation>Wang J, Yuan X. Digestive system symptoms and function in children with COVID&#x2010;19: a meta&#x2010;analysis. Medicine (Baltimore). 2021;100:e24897.</Citation></Reference><Reference><Citation>Zhang H, Li HB, Lyu JR, et&#xa0;al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019&#x2010;nCoV infection. Int J Infect Dis. 2020;96:19&#x2010;24.</Citation></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et&#xa0;al. Post&#x2010;COVID&#x2010;19 symptoms 6 months after acute infection among hospitalized and non&#x2010;hospitalized patients. Clin Microbiol Infect. 2021;27:1507&#x2010;1513.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>